Literature DB >> 23928905

Potassium loss from chlorhexidine-treated bacterial pathogens is time- and concentration-dependent and variable between species.

Noelle H O'Driscoll1, Olga Labovitiadi, T P Tim Cushnie, Kerr H Matthews, Andrew J Lamb.   

Abstract

The membrane-active antimicrobial agent chlorhexidine is used extensively as an antiseptic during infection prophylaxis and treatment. Whilst known to induce membrane damage that results in loss of internal solutes from bacteria, the present study sought to determine the rate and extent of cytoplasmic potassium loss and whether any species-specific differences exist. Direct measurement of potassium was achieved using flame emission spectrophotometry. Exposure of selected species to minimum inhibitory (MIC) or minimum bactericidal concentration (MBC) resulted in solute loss that was both concentration and time dependent. Within 5-min treatment with MIC levels, losses of 3 % from P. aeruginosa, 9 % from E. coli, and 15 % from S. aureus were recorded, whilst at 5 % w/v chlorhexidine, elevated loss of 20, 28, and 41 % occurred, respectively. Nonlinear potassium release was evident from all species when treated with 5 % chlorhexidine over a 60-min period. After this contact time, potassium loss from E. coli and S. aureus rose to 93 or 90 %, respectively; in contrast, P. aeruginosa retained 62 % intracellular potassium. Results confirm lethal concentrations of chlorhexidine induce rapid and substantial loss of cytoplasmic potassium from common pathogens. However, bacterial responses vary between species and should be borne in mind when considering mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928905     DOI: 10.1007/s00284-013-0433-3

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  16 in total

1.  The membrane destabilising action of the antibacterial agent chlorhexidine.

Authors:  K Barrett-Bee; L Newboult; S Edwards
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

2.  Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility.

Authors:  U Tattawasart; J Y Maillard; J R Furr; A D Russell
Journal:  J Hosp Infect       Date:  1999-07       Impact factor: 3.926

3.  Comparison of the antibacterial efficacy of 4% chlorhexidine gluconate and 1% triclosan handwash products in an acute clinical ward.

Authors:  J L Faoagali; N George; J Fong; J Davy; M Dowser
Journal:  Am J Infect Control       Date:  1999-08       Impact factor: 2.918

4.  Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri.

Authors:  U Tattawasart; A C Hann; J Y Maillard; J R Furr; A D Russell
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

5.  Comparative susceptibility of hospital isolates of gram-negative bacteria to antiseptics and disinfectants.

Authors:  S A Hammond; J R Morgan; A D Russell
Journal:  J Hosp Infect       Date:  1987-05       Impact factor: 3.926

6.  In vitro efficacy of antimicrobial wafers against methicillin-resistant Staphylococcus aureus.

Authors:  Olga Labovitiadi; Andrew J Lamb; Kerr H Matthews
Journal:  Ther Deliv       Date:  2012-04

7.  Lyophilised wafers as vehicles for the topical release of chlorhexidine digluconate--release kinetics and efficacy against Pseudomonas aeruginosa.

Authors:  Olga Labovitiadi; Andrew J Lamb; Kerr H Matthews
Journal:  Int J Pharm       Date:  2012-10-17       Impact factor: 5.875

8.  Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application.

Authors:  Noelle H O'Driscoll; Olga Labovitiadi; T P Tim Cushnie; Kerr H Matthews; Derry K Mercer; Andrew J Lamb
Journal:  Curr Microbiol       Date:  2012-11-25       Impact factor: 2.188

9.  Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli.

Authors:  Hon-Yeung Cheung; Matthew Man-Kin Wong; Sau-Ha Cheung; Longman Yimin Liang; Yun-Wah Lam; Sung-Kay Chiu
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

Review 10.  Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review.

Authors:  Lennie P G Derde; Mirjam J D Dautzenberg; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.